Tamarix
Tamarix43About
What does Tamarix do?
Tamarix Pharma is an early-stage biotechnology company focused on developing novel technologies that restore physiological balance in apoptosis-related diseases. Their lead assets, VBIT-4 and VBIT-12, are designed to target a key mitochondrial process known as VDAC1 oligomerization.
What is Tamarix's revenue?
StartupHub estimates Tamarix's annual revenue at $339K (range $191K to $534K, 64% confidence), based on comparable companies in the sector.
What is Tamarix's valuation?
StartupHub estimates Tamarix's effective valuation at $57.9M (range $37.5M to $90.0M, 10% confidence), based on comparable companies in the sector.
How much funding has Tamarix raised?
Tamarix has raised a total of $15M in funding. The most recent round on record is Seed.
Where is Tamarix headquartered?
Tamarix is headquartered in San Diego, United States.
When was Tamarix founded?
Tamarix was founded in 2020.
What industry does Tamarix operate in?
Tamarix operates in Life Sciences, Biopharmaceutical, Biotech, Drug Discovery, Clinical Trials, MedTech.
How many employees does Tamarix have?
Tamarix has approximately 2 people on record.
What is Tamarix's current status?
Tamarix's current operating status is: Inactive.
No comments yet. Be the first to share your take.